Tender Description
Notice type: Combined Synopsis/Solicitation · NAICS 518210 · PSC B529 · Place of performance: Silver Spring, MD FDA/CDER requires access to national-level pharmaceutical sales data to estimate and forecast trends in pharmaceutical sales, pricing, and volume of distribution throughout various settings of care. Continued access to these data allows the FDA to respond expeditiously to questions relating to drug safety, the impact of regulatory policies, and to potential drug shortage situations, helping the Agency to make more informed decisions about matters that affect the health of Americans. See Attachments for RFP and related attachments.
- Country
- United States
- Published
- 30 Aug 2022
- Closing date
- 09 Sept 2022
- Procedure
- Combined Synopsis/Solicitation
